Alzheimer's disease: a new hope.
Until recently, the diagnosis and treatment of Alzheimer's disease was limited. This article describes the outcome of new research and advances in the pharmacological treatment of this disease, especially the use of Cognex (tacrine). It also reports on a multicenter study of tacrine we participated in with patients at Raleigh Psychiatric Services, Inc. in Beckley.
Hasan
M K
MK
Department of Psychiatry, Beckley Appalachian Regional Hospital.
Mooney
D
D
D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics; D053327:Apolipoprotein E4; D001057:Apolipoproteins E / Q000235:genetics; D005260:Female; D006801:Humans; D008297:Male; D012307:Risk Factors; D013619:Tacrine / Q000009:adverse effects / Q000627:therapeutic use*
D053327:Apolipoprotein E4; D001057:Apolipoproteins E; D013619:Tacrine